Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

BeOne Medicines Ltd. - American Depositary Shares (NQ:ONC)

335.17 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	335.17
Bid (Size)	340.20 (40)
Ask (Size)	346.99 (80)
Prev. Close	335.17
Today's Range	335.17 - 335.17
52wk Range	172.67 - 385.22
Shares Outstanding	1,211,067,023
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

BeOne Medicines Showcases Leadership in B-cell Malignancies at ASH 2025

November 20, 2025

From BeOne Medicines Ltd.

Via Business Wire

Zymeworks, Jazz Pharmaceuticals Stocks Climb On Robust Gastroesophageal Trial Outcomes And Upcoming Regulatory Plans ↗

November 17, 2025

Zymeworks rises after Ziihera shows significant PFS and OS benefits in a Phase 3 trial, supporting plans for regulatory filings and guideline submissions.

Via Benzinga

Performance

YTD	+82.2%	+82.2%
1 Month	+6.3%	+6.3%
3 Month	+8.5%	+8.5%
6 Month	+40.6%	+40.6%
1 Year	+82.2%	+82.2%

More News

Positive Phase 3 Results Support ZIIHERA® as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA® and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma

November 17, 2025

From BeOne Medicines Ltd.

Via Business Wire

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Where BeOne Medicines Stands With Analysts ↗

October 08, 2025

Via Benzinga

BeOne Medicines Announces Third Quarter 2025 Financial Results and Business Updates

November 06, 2025

From BeOne Medicines Ltd.

Via Business Wire

BeOne Medicines to Present at Upcoming Investor Conferences

October 28, 2025

From BeOne Medicines Ltd.

Via Business Wire

Investor Exits $5.5 Million Perpetua Resources Stake Amid Stock's 150% Rally ↗

October 27, 2025

Via The Motley Fool

Analyst Expectations For BeOne Medicines's Future ↗

September 18, 2025

Via Benzinga

BeOne Medicines to Announce Third Quarter 2025 Financial Results on November 6

October 22, 2025

From BeOne Medicines Ltd.

Via Business Wire

What's Going On With Summit Therapeutics Stock On Monday? ↗

October 20, 2025

Via Benzinga

BeOne Medicines Presents New Data on TEVIMBRA in Lung Cancer at ESMO 2025

October 20, 2025

From BeOne Medicines Ltd.

Via Business Wire

BeOne Medicines’ Sonrotoclax Granted Breakthrough Therapy Designation by U.S. FDA

October 13, 2025

From BeOne Medicines Ltd.

Via Business Wire

China-Tied Biotechs Zai Labs, BeOne Plunge On Rumored Executive Order ↗

September 10, 2025

Via Investor's Business Daily

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 10, 2025

Via Benzinga

Wayfair, United Therapeutics, And Ciena Are Among The Top 10 Large-Cap Gainers Last Week (July 14-July 18): Are The Others In Your Portfolio? ↗

September 07, 2025

Via Benzinga

Air Lease, Ionis Pharmaceuticals, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday ↗

September 02, 2025

Via Benzinga

Why Carisma Therapeutics Shares Are Trading Higher By 133%; Here Are 20 Stocks Moving Premarket ↗

September 02, 2025

Via Benzinga

BeOne Medicines Stock Gains Momentum With Early-Stage Trial Success For Pretreated Lymphoma Patients ↗

August 29, 2025

Via Benzinga

Affirm Posts Better-Than-Expected Earnings, Joins Ambarella, IREN, Petco Health and Wellness And Other Big Stocks Moving Higher On Friday ↗

August 29, 2025

Via Benzinga

BeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma (MCL)

August 29, 2025

From BeOne Medicines Ltd.

Via Business Wire

European Commission Approves TEVIMBRA® as Neoadjuvant/Adjuvant NSCLC Treatment Ahead of Late-Breaking Data Presentation at WCLC 2025

August 27, 2025

From BeOne Medicines Ltd.

Via Business Wire

BeOne to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

August 26, 2025

From BeOne Medicines Ltd.

Via Business Wire

BeOne Cashes In On Amgen's Cancer Drug Royalties In Multibillion-Dollar Pharma Tie-Up ↗

August 25, 2025

Via Benzinga

BeOne Medicines Announces IMDELLTRA Royalty Purchase Agreement for up to $950 Million

August 25, 2025

From BeOne Medicines Ltd.

Via Business Wire

Frequently Asked Questions

Is BeOne Medicines Ltd. - American Depositary Shares publicly traded?

Yes, BeOne Medicines Ltd. - American Depositary Shares is publicly traded.

What exchange does BeOne Medicines Ltd. - American Depositary Shares trade on?

BeOne Medicines Ltd. - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for BeOne Medicines Ltd. - American Depositary Shares?

The ticker symbol for BeOne Medicines Ltd. - American Depositary Shares is ONC on the Nasdaq Stock Market

What is the current price of BeOne Medicines Ltd. - American Depositary Shares?

The current price of BeOne Medicines Ltd. - American Depositary Shares is 335.17

When was BeOne Medicines Ltd. - American Depositary Shares last traded?

The last trade of BeOne Medicines Ltd. - American Depositary Shares was at 11/25/25 04:00 PM ET

What is the market capitalization of BeOne Medicines Ltd. - American Depositary Shares?

The market capitalization of BeOne Medicines Ltd. - American Depositary Shares is 405.91B

How many shares of BeOne Medicines Ltd. - American Depositary Shares are outstanding?

BeOne Medicines Ltd. - American Depositary Shares has 406B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.